Optimal insulin therapy could prevent hyperglycemia-related complications from the first trimester, when hyperglycemia can negatively affect the normal development of the embryo, resulting in congenital malformations, to the last trimester of pregnancy, when it can prevent macrosomia, neonatal complications and even stillbirth. This evidence concerns the gene INS and Stillbirth.